Summary
Panvax H1N1 approval for Australian use by therapeutics means will have a Preventive & curative effects in global pandemic control of swine Flu.
Analysis
PanvaxH1N1 approval for registration for use in Australia by therapeutic goods administration will give an immense boom for global Swine flu Pandemic Control by exerting its Curative effects, which in long run will give automatic Preventive effects for swine flu control in whole world. This approval will open up new avenues in treatment and prevention of not only Swine Flu but also other unknown types of Influenzas.The Influenza viruses are notorious for their mutagenicity & non response to even specific vaccines for which the requirement is constant research, the datas for which can be provided by such approvals.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
